Phase 2 Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years of age or older
- You have been diagnosed with a specific type of cancer in the head of the pancreas (pancreatic adenocarcinoma, duodenal adenocarcinoma, ampullary adenocarcinoma, or a cyst-related cancer called IPMN with adenocarcinoma), confirmed by a specialist scan and tissue sample
- A team of medical experts has agreed that surgery to remove the tumour is a suitable option for you
- Before surgery, you show 2 or more signs that suggest a higher risk of a specific post-surgery complication (such as being male, having a BMI of 30 or above, having a small pancreatic duct, having excess abdominal fat, or having low muscle mass) — and this higher risk is also confirmed during the operation itself
- If you are a woman who could become pregnant, you have had a recent menstrual period and a negative pregnancy test, and you agree to monthly pregnancy testing during the chemotherapy part of the trial
- If you are a woman who could become pregnant, or a male participant whose partner could become pregnant, you agree to use highly effective contraception during chemotherapy and for a set period afterwards (6 months for women, 1 month for men)
- You are covered by a health insurance system
- You have read and signed a consent form agreeing to take part in the study
Who may not be able to join:
- You have a specific type of diabetes identified by a pre-surgery blood test showing very low insulin production (confirm with trial site)
- You have a known or strongly suspected inherited genetic condition linked to pancreatic cancer risk (such as familial pancreatic cancer, Lynch syndrome, Peutz-Jeghers syndrome, Li-Fraumeni syndrome, or several other hereditary conditions)
- Your cancer has been found in more than one area of the pancreas before surgery
- Your overall health or other medical conditions make major abdominal surgery unsuitable
- There is a medical reason why you cannot receive a specific procedure involving transplanting insulin-producing cells into a vein in your liver (confirm with trial site)
- You are currently receiving, or are planned to receive, chemotherapy before surgery (neoadjuvant chemotherapy)
- Your cancer has already spread outside the pancreas, as identified before or during surgery
- You would need complex reconstruction of major blood vessels as part of your surgery
- There are signs of inflammation of the pancreas linked to a bile drain that could interfere with the cell isolation process (confirm with trial site)
- You have a known infection or positive blood test for HIV, Hepatitis B or C, HTLV, or syphilis
- You currently have an active COVID-19 infection (positive PCR test) — in this case, the procedure would need to be rescheduled at least 30 days later
- You are pregnant or currently breastfeeding
- You have a complete deficiency of an enzyme called dihydropyrimidine dehydrogenase, which affects how the body processes certain chemotherapy drugs
- You are unable to understand the purpose, benefits, and risks of the study, or cannot give written consent
- You are unable to follow the full schedule of the trial
- You are not covered by a health insurance system
- You are currently detained, receiving certain types of psychiatric care, living in a care institution, or are in an emergency situation
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: François PATTOU, MD,PhD, University Hospital, Lille
Phone: 0320445962
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
the rate of patients who have completed the chemotherapy planned
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.